FDA Inspection 1024855 — Melinta Therapeutics, Inc.
The FDA completed an inspection of Melinta Therapeutics, Inc. on Apr 14, 2017 in Lincolnshire, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lincolnshire, IL (United States)
Additional details
Sponsor, Contract Research Organization